Equity Analysis /
United States of America

US : Viking Therapeutics, Inc. - VKTX | 1Q22 Update: GLP-1/GIP Phase 1 Underway; Bought Back Stock (~$5M)

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    27 April 2022
    Published byCGS-CIMB